A Phase 1 Study to Assess the Safety, Tolerability, and Pharmacokinetic Profile of a Single Doses of MMV533.
Clinical trial NCT04323306 · COMPLETED
Trial details
- NCT number
- NCT04323306
- Sponsor
- Medicines for Malaria Venture
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-08-12
- Primary completion
- 2022-09-27
- Enrollment
- 72
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.